Right to Try law clears path for cancer drug

Tuesday, October 8, 2019
 | 
Chris Woodward (OneNewsNow.com)

hospital surgeryThere's new hope for Americans suffering from a deadly form of brain cancer.

An anti-cancer vaccine known as Gliovac will be made available to patients suffering from glioblastoma, a rare and fatal cancer with a devastating five-year survival rate of about five percent.

Gliovac has not received final approval by the U.S. Food and Drug Administration (FDA) but thanks to the recently enacted federal Right to Try law, Epitopoietic Research Corporation (ERC), the vaccine's manufacturer, has announced a program offering Gliovac to patients who meet certain eligibility requirements.

President Trump signed the Right to Try bill in May 2018.

"The really exciting part of this announcement is that there are people who now have another shot at trying to save their own lives," says Naomi Lopez Bauman, director of healthcare policy at the Arizona-based Goldwater Institute, which helped develop the Right to Try policy. "Whenever they've run out of hope, whenever they don't qualify for any more treatment, they've run out of options, there may still be another pathway."

Lopez Bauman acknowledges that some terminally-ill patients and others who do not qualify for clinical trials may not find another path. For example, the physician has to recommend the treatment and the manufacturer has to be willing to make the treatment available.

"But when that is possible,” she says, “you don't have to beg the federal government for permission to try save your own life."

Comments

We moderate all reader comments, usually within 24 hours of posting (longer on weekends). Please limit your comment to 300 words or less and ensure it addresses the article - NOT another reader's comments. Comments that contain a link (URL), an inordinate number of words in ALL CAPS, rude remarks directed at other readers, or profanity/vulgarity will not be approved. More details

FEATURED PODCAST

SIGN UP FOR OUR DAILY NEWSBRIEF

SUBSCRIBE

VOTE IN OUR POLL

Besides the economy & unemployment rate, what are other factors favoring a second Trump term?

CAST YOUR VOTE

GET PUSH NOTIFICATIONS

SUBSCRIBE

LATEST AP HEADLINES

  Devastating factory fire kills at least 43 in Indian capital
  In Florida, Trump says he's Israel's friend in White House
  N. Korea conducts ‘important test’ at once-dismantled site
Aging survivors return to Pearl Harbor to recall ’41 attack
Official: Base shooter watched shooting videos before attack
American Samoa declares measles outbreak, closes schools
Iran frees Chinese-American scholar for US-held scientist
PG&E says it has reached $13.5 billion wildfire settlement
Lebanon’s journalists suffer abuse, threats covering unrest

LATEST FROM THE WEB

Navy IDs 3 victims of NAS Pensacola shooting; military calls for increased security checks
Iran says new budget bucks US oil embargo, uses Russian loan
House releases 'constitutional grounds for presidential impeachment'
Devin Nunes on phone record release: 'We're definitely going to take legal action'
Naval officer murdered in Pensacola shooting remembered as a hero who 'saved countless lives'

CARTOON OF THE DAY

Cartoon of the Day
NEXT STORY
Information is power – and 'big tech' has both

technology (generic)The major technology companies could have more national security data than the federal government, according to a panel of experts at The Heritage Foundation.